Senolytic Therapy to Modulate Progression of Alzheimer's Disease

Condition:   Alzheimer Disease Intervention:   Drug: Dasatinib + Quercetin Sponsors:   The University of Texas Health Science Center at San Antonio;   Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials